Cancer and Trypanosoma cruzi: Tumor induction or protection?

被引:5
作者
Franco, Pablo Igor Ribeiro [1 ,4 ]
Neto, Jose Rodrigues do Carmo [1 ]
Miguel, Marina Pacheco [1 ,2 ]
Machado, Juliana Reis [3 ]
Celes, Mara Rubia Nunes [1 ]
机构
[1] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Biosci & Technol, BR-74605050 Goiania, GO, Brazil
[2] Univ Fed Goias, Vet & Anim Sci Sch, BR-74605050 Goiania, GO, Brazil
[3] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Dept Gen Pathol, BR-38025180 Uberaba, MG, Brazil
[4] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Postgrad Program Trop Med & Publ Hlth, BR-74605050 Goiania, GO, Brazil
关键词
Chagas disease; Neoplasms; Host -parasite interactions; Trypanosoma cruzi; DNA MISMATCH REPAIR; CHAGAS-DISEASE; ENTERIC GLIA; COLON-CANCER; CALRETICULIN; ESOPHAGEAL; CARCINOMA; MEGACOLON; PROMOTES; PATHWAY;
D O I
10.1016/j.biochi.2022.10.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Trypanosoma cruzi causes Chagas disease, a neglected disease that can be divided, overall, into acute and chronic phases. Understanding the mechanisms underlying its progression is based on the parasite-host interactions occurring during the infection. Although the pathophysiology of the main symptomatic forms of Chagas disease has been the subject of several studies, little is known about their relationship with the development of different types of cancer. Therefore, knowledge regarding the molecular aspects of infection in the host, as well as the influence of the immune response in the parasite and the host, can help to understand the association between Chagas disease and tumor development. This review aims to summarize the main molecular mechanisms related to T. cruzi-dependent carcinogenic development and the mechanisms associated with tumor protection mediated by different parasite components.(c) 2022 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 97 条
  • [1] Adad Sheila Jorge, 2002, Rev. Soc. Bras. Med. Trop., V35, P63, DOI 10.1590/S0037-86822002000100012
  • [2] Leiomyosarcoma of the esophagus in a patient with Chagasic megaesophagus: Case report and literature review
    Adad, SJ
    Etchebehere, RM
    Hayashi, EM
    Asai, RK
    Fernandes, PD
    Macedo, CFC
    Crema, E
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (05) : 879 - 881
  • [3] Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo
    Aguilar-Guzman, Lorena
    Lobos-Gonzalez, Lorena
    Rosas, Carlos
    Vallejos, Gerardo
    Falcon, Cristian
    Sosoniuk, Eduardo
    Coddou, Francisca
    Leyton, Lisette
    Lemus, David
    Quest, Andrew F. G.
    Ferreira, Arturo
    [J]. PLOS ONE, 2014, 9 (04):
  • [4] A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells
    Atayde, Vanessa D.
    Jasiulionis, Miriam G.
    Cortez, Mauro
    Yoshida, Nobuko
    [J]. MELANOMA RESEARCH, 2008, 18 (03) : 172 - 183
  • [5] Molecular cloning and characterization of the DNA mismatch repair gene class 2 from the Trypanosoma cruzi
    Augusto-Pinto, L
    Bartholomeu, DC
    Teixeira, SMR
    Pena, SDJ
    Machado, CR
    [J]. GENE, 2001, 272 (1-2) : 323 - 333
  • [6] In vivo anticancer activity of lysates from Trypanosoma cruzi of different genetic groups
    Batmonkh, Zetsegsaikhan
    Kallinikova, V. D.
    Pakhorukova, L. V.
    Kravtsov, E. G.
    Karpenko, L. P.
    Dalin, M. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 142 (04) : 470 - 473
  • [7] Pathology and Pathogenesis of Chagas Heart Disease
    Bonney, Kevin M.
    Luthringer, Daniel J.
    Kim, Stacey A.
    Garg, Nisha J.
    Engman, David M.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14, 2019, 14 : 421 - 447
  • [8] The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells
    Borges, Bruna Cristina
    Uehara, Isadora Akemi
    dos Santos, Marlus Alves
    Martins, Flavia Alves
    de Souza, Fernanda Carvalho
    Junior, Alvaro Ferreira
    da Luz, Felipe Andres Cordero
    da Costa, Mylla Spirandelli
    Notario, Ana Flavia Oliveira
    Lopes, Daiana Silva
    Teixeira, Samuel Cota
    Teixeira, Thaise Lara
    de Castilhos, Patricia
    da Silva, Claudio Vieira
    Silva, Marcelo Jose Barbosa
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [9] Chagas' disease: an update on immune mechanisms and therapeutic strategies
    Boscardin, Silvia Beatriz
    Troccoli Torrecilhas, Ana Claudia
    Manarin, Romina
    Revelli, Silvia
    Gonzalez Rey, Elena
    Tonelli, Renata Rosito
    Silber, Ariel Mariano
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) : 1373 - 1384
  • [10] TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
    Bouaoun, Liacine
    Sonkin, Dmitriy
    Ardin, Maude
    Hollstein, Monica
    Byrnes, Graham
    Zavadil, Jiri
    Olivier, Magali
    [J]. HUMAN MUTATION, 2016, 37 (09) : 865 - 876